• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume8, Issue4

CLINICAL PROGNOSTIC FACTORS IN OROPHARYNEAL CARCINOMA PATIENTS TREATED WITH CONCURRENT CHEMORADIATION.

    Dr Sonali Karnwal, Dr Raja Paramjeet Singh Benipal, Dr Jai Lal, Dr Pardeep Garg, Dr Manraj Singh Kang, Dr Romi Kant Grover

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 72-78

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Worldwide, oropharyngealcancer accounts for 1.6% of all the new cases and 1.5% deaths in 2020. Overall42176, is the incidence of oropharyngeal cancers occuring in Asia, and account for approximately 30% of all the cancers in India. Oropharyngeal carcinoma is eleventh most common cancer worldwide and accounts for approximately 10 per cent of the annual worldwide incidence of head and neck squamous cell carcinoma. In India, head and neck cancers contribute up to 7.8% of the global cancer burden and 8.33% of the global cancer deaths.In 2020, the incidence of oropharynx cancer worldwide is 98,412 1. In India incidence rate is 6794 2. Incidence rates are more than twice as high in men as in women3.The tonsil is the most frequent subsite of oropharyngeal cancer followed by the base of tongue.
Keywords:
    Worldwide oropharyngealcancer accounts for 1.6% of all the new cases and 1.5% deaths in 2020
  • PDF (177 K)
  • XML
(2021). CLINICAL PROGNOSTIC FACTORS IN OROPHARYNEAL CARCINOMA PATIENTS TREATED WITH CONCURRENT CHEMORADIATION.. European Journal of Molecular & Clinical Medicine, 8(4), 72-78.
Dr Sonali Karnwal, Dr Raja Paramjeet Singh Benipal, Dr Jai Lal, Dr Pardeep Garg, Dr Manraj Singh Kang, Dr Romi Kant Grover. "CLINICAL PROGNOSTIC FACTORS IN OROPHARYNEAL CARCINOMA PATIENTS TREATED WITH CONCURRENT CHEMORADIATION.". European Journal of Molecular & Clinical Medicine, 8, 4, 2021, 72-78.
(2021). 'CLINICAL PROGNOSTIC FACTORS IN OROPHARYNEAL CARCINOMA PATIENTS TREATED WITH CONCURRENT CHEMORADIATION.', European Journal of Molecular & Clinical Medicine, 8(4), pp. 72-78.
CLINICAL PROGNOSTIC FACTORS IN OROPHARYNEAL CARCINOMA PATIENTS TREATED WITH CONCURRENT CHEMORADIATION.. European Journal of Molecular & Clinical Medicine, 2021; 8(4): 72-78.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 199
  • PDF Download: 234
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus